Agios Pharmaceuticals Inc. Revenue 2011–2025
Agios Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Agios Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 20.7 M, a 137.75% increase year-over-year.
- Agios Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 54.8 M, a 65.25% increase year-over-year.
- Agios Pharmaceuticals Inc. annual revenue for 2025 was 54.0 M, a 48.03% increase from 2024.
- Agios Pharmaceuticals Inc. annual revenue for 2024 was 36.5 M, a 36.07% increase from 2023.
- Agios Pharmaceuticals Inc. annual revenue for 2023 was 26.8 M, a 88.36% increase from 2022.
- Agios Pharmaceuticals Inc. annual revenue for 2022 was 14.2 M.
Agios Pharmaceuticals Inc. (AGIO) — Frequently Asked Questions
Agios Pharmaceuticals Inc. (AGIO) is a publicly traded US company. It has a market capitalization of $1.66B. In fiscal 2025 it reported revenue of $54M and net income of -$413M. Explore AGIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Agios Pharmaceuticals Inc.'s market cap?
Agios Pharmaceuticals Inc. (AGIO) has a market capitalization of $1.66B.
What is the AGIO stock price?
AGIO trades at $28.72 (-0.55% on the day).
How much revenue does Agios Pharmaceuticals Inc. make?
Agios Pharmaceuticals Inc. reported revenue of $54M in fiscal 2025.
Is AGIO profitable?
In fiscal 2025, Agios Pharmaceuticals Inc. reported net income of -$413M.